ALPHA TRIBE

GlaxoSmithKline Pharmaceuticals LimitedUpdates, 25-08-2025: Press Release

25-08-2025 | 11:07 am

GSK enters India's oncology market, launching precision therapies Jemperli and Zejula for advanced gynaecological cancers. This move addresses critical unmet needs in endometrial and ovarian cancer, significantly strengthening GSK's specialty medicine portfolio in India.

No comments yet. Be the first to comment!

All announcements from GlaxoSmithKline Pharmaceuticals Limited